KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 26 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $25,679,000 | +18.6% | 1,719,576 | 0.0% | 12.37% | +12.8% |
| Q3 2020 | $21,650,000 | +4.1% | 1,719,576 | 0.0% | 10.97% | -24.0% |
| Q2 2020 | $20,806,000 | +58.2% | 1,719,576 | 0.0% | 14.43% | +30.8% |
| Q1 2020 | $13,155,000 | -57.0% | 1,719,576 | 0.0% | 11.03% | -40.5% |
| Q4 2019 | $30,625,000 | +53.5% | 1,719,576 | 0.0% | 18.55% | +32.4% |
| Q3 2019 | $19,947,000 | -47.6% | 1,719,576 | 0.0% | 14.01% | -45.2% |
| Q2 2019 | $38,088,000 | -27.3% | 1,719,576 | -6.1% | 25.57% | -16.9% |
| Q1 2019 | $52,419,000 | +4.2% | 1,831,548 | -28.1% | 30.75% | -0.8% |
| Q4 2018 | $50,327,000 | -11.8% | 2,548,202 | -1.2% | 30.98% | +85.5% |
| Q3 2018 | $57,033,000 | +172.3% | 2,579,490 | 0.0% | 16.70% | +73.7% |
| Q2 2018 | $20,945,000 | -14.3% | 2,579,490 | 0.0% | 9.62% | -47.6% |
| Q1 2018 | $24,453,000 | -2.8% | 2,579,490 | 0.0% | 18.34% | +38.0% |
| Q4 2017 | $25,150,000 | +44.9% | 2,579,490 | 0.0% | 13.28% | +0.9% |
| Q3 2017 | $17,360,000 | -8.6% | 2,579,490 | 0.0% | 13.16% | -35.6% |
| Q2 2017 | $18,985,000 | -5.8% | 2,579,490 | 0.0% | 20.43% | -8.2% |
| Q1 2017 | $20,146,000 | +10.5% | 2,579,490 | 0.0% | 22.25% | +44.9% |
| Q4 2016 | $18,237,000 | – | 2,579,490 | – | 15.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |